IN166946B - - Google Patents

Info

Publication number
IN166946B
IN166946B IN197/MAS/88A IN197MA1988A IN166946B IN 166946 B IN166946 B IN 166946B IN 197MA1988 A IN197MA1988 A IN 197MA1988A IN 166946 B IN166946 B IN 166946B
Authority
IN
India
Prior art keywords
melatonin
progestogen
ovulation
estrogen
women
Prior art date
Application number
IN197/MAS/88A
Other languages
English (en)
Inventor
Michael Cohen
Original Assignee
Applied Med Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Med Res filed Critical Applied Med Res
Publication of IN166946B publication Critical patent/IN166946B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Indole Compounds (AREA)
  • Seeds, Soups, And Other Foods (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
IN197/MAS/88A 1987-03-23 1988-03-28 IN166946B (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/029,229 US4855305A (en) 1987-03-23 1987-03-23 Compositions and methods of effecting contraception utilizing melatonin
PCT/US1988/000971 WO1988007370A1 (en) 1987-03-23 1988-03-22 Compositions and methods of effecting contraception and control of breast cancer

Publications (1)

Publication Number Publication Date
IN166946B true IN166946B (ja) 1990-08-11

Family

ID=21847942

Family Applications (1)

Application Number Title Priority Date Filing Date
IN197/MAS/88A IN166946B (ja) 1987-03-23 1988-03-28

Country Status (26)

Country Link
US (1) US4855305A (ja)
EP (1) EP0354921B1 (ja)
JP (2) JP2965160B2 (ja)
KR (1) KR890700349A (ja)
CN (1) CN1041383C (ja)
AT (1) ATE143807T1 (ja)
AU (3) AU628784B2 (ja)
BG (1) BG51075A1 (ja)
BR (1) BR8807426A (ja)
CA (1) CA1322527C (ja)
DD (1) DD269557A5 (ja)
DE (1) DE3855606T2 (ja)
EG (1) EG18583A (ja)
ES (1) ES2009251A6 (ja)
FI (1) FI894423A (ja)
GR (1) GR1002146B (ja)
HU (1) HU208487B (ja)
IL (1) IL85814A (ja)
IN (1) IN166946B (ja)
NZ (1) NZ223989A (ja)
OA (1) OA09134A (ja)
PH (1) PH26709A (ja)
PT (1) PT87053B (ja)
RU (1) RU2114621C1 (ja)
WO (1) WO1988007370A1 (ja)
ZA (1) ZA882079B (ja)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR1001395B (el) * 1987-03-23 1993-10-29 Michael Cohen Συν?έσεις και μέ?οδοι προς πραγματοποίηση αντισύλληψης.
EP0300630A3 (en) * 1987-07-03 1990-03-28 Schering Agrochemicals Limited Melatonin for regulating animal reproduction
EP0305194A3 (en) * 1987-08-28 1990-03-28 Schering Agrochemicals Limited Veterinary composition
IN170311B (ja) * 1989-01-17 1992-03-14 Cohen Michael
GR900100024A (el) * 1989-01-17 1991-06-07 Amr Int Μέθοδος θεραπείας του προεμμηνορροϊκού συνδρόμου.
US4945103A (en) * 1989-01-17 1990-07-31 Michael Cohen Method of treating pre-menstrual syndrome
AU644367B2 (en) * 1989-05-17 1993-12-09 Applied Medical Research Ltd Use of melatonin derivatives for effecting contraception
NZ233697A (en) * 1989-05-17 1996-12-20 Applied Med Res Ltd Contraceptive composition comprising a melatonin analogue and a progestogen and/or an estrogen
IT1243193B (it) * 1990-08-10 1994-05-24 Medea Res Srl Composizioni farmaceutiche orali a base di melatonina
DK0483077T3 (da) * 1990-09-28 1996-04-15 I F L O S A S Di Giorgio E Ald Fremgangsmåde til syntese af et kontraceptivt og menstruationscyklus-kontrollerende lægemiddel med onkostatiske, antikinetosiske, præventive og terapeutiske egenskaber til behandling af brysttumorer og melanomer
DE122007000073I1 (de) * 1991-05-09 2008-01-31 Neurim Pharma 1991 Melatonin enthaltene Arzneimittel
PT100973A (pt) * 1991-10-18 1994-06-30 Alza Corp Dispositivo e composicoes farmaceuticas para a administracao de melatonina por via transdermica
US5196435A (en) * 1991-11-21 1993-03-23 Eli Lilly And Company Melatonin derivatives and combinations with antiestrogen compounds for treating mammalian breast carcinoma
ATE141051T1 (de) * 1992-04-07 1996-08-15 Neurim Pharma 1991 Verwendung von melatonin zur herstellung eines arzneimittels zur behandlung der gutartigen prostatahyperplasie
US6403631B1 (en) 1995-11-24 2002-06-11 Equitech Laboratories, Inc. Method and compositions for enhancing pregnancy success in an animal
US5792785A (en) * 1995-11-24 1998-08-11 Equitech Laboratories, Inc. Method for enhancing pregnancy success in an animal
US6028064A (en) * 1996-09-13 2000-02-22 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of progestin products
US6620836B1 (en) * 1997-01-22 2003-09-16 Jay Patrick Antiarrhythmic and tranquilizer composition and treatment
DE19739916C2 (de) * 1997-09-11 2001-09-13 Hesch Rolf Dieter Verwendung einer Kombination aus einem Gestagen und einem Estrogen zur kontinuierlichen Ovulationshemmung und ggf. gleichzeitigen Behandlung und/oder Prophylaxe von Tumoren der Brustdrüsen
AU747710B2 (en) 1997-11-14 2002-05-23 Akzo Nobel N.V. Progestogen-antiprogestogen regimens
US6133453A (en) * 1998-05-15 2000-10-17 Pharm-Eco Laboratories, Inc. Method for making substituted indoles
US6855703B1 (en) 2000-03-10 2005-02-15 Endeavor Pharmaceuticals Pharmaceutical compositions of conjugated estrogens and methods of analyzing mixtures containing estrogenic compounds
US7989436B2 (en) 2003-07-23 2011-08-02 Duramed Pharmaceuticals, Inc. Estrogenic compounds and pharmaceutical formulations comprising the same
US7459445B2 (en) * 2000-03-10 2008-12-02 Duramed Pharmaceuticals, Inc. Estrogenic compounds and topical pharmaceutical formulations of the same
US6660726B2 (en) * 2000-03-10 2003-12-09 Endeavor Pharmaceuticals Estrogenic compounds, pharmaceutical compositions thereof, and methods of using same
US20040176336A1 (en) * 2000-03-21 2004-09-09 Rodriguez Gustavo C. Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium
US20050113351A1 (en) * 2000-03-21 2005-05-26 Rodriguez Gustavo C. Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium
PT1315502E (pt) * 2000-08-30 2010-05-06 Unimed Pharmaceuticals Llc Método para tratar a disfunção eréctil e para aumentar a líbido em homens
US6503894B1 (en) 2000-08-30 2003-01-07 Unimed Pharmaceuticals, Inc. Pharmaceutical composition and method for treating hypogonadism
US20030139384A1 (en) * 2000-08-30 2003-07-24 Dudley Robert E. Method for treating erectile dysfunction and increasing libido in men
AU2003230644A1 (en) * 2002-03-14 2003-09-29 Ercole L. Cavalieri A unifying mechanism and methods to prevent cancer and neurodegenerative diseases
US6992075B2 (en) * 2003-04-04 2006-01-31 Barr Laboratories, Inc. C(14) estrogenic compounds
CA2521471A1 (en) * 2003-04-11 2004-10-28 Barr Laboratories, Inc. Methods of administering estrogens and progestins
PL1663197T3 (pl) 2003-09-09 2008-09-30 Biogen Idec Int Gmbh Zastosowanie pochodnych kwasu fumarowego do leczenia niewydolności serca oraz astmy
CA2566811A1 (en) * 2004-05-26 2005-12-15 Wyeth Compositions and methods for treatment of premenstrual dysphoric disorder
DK1799196T3 (en) 2004-10-08 2016-08-15 Forward Pharma As Controlled release pharmaceutical compositions comprising a fumaric acid ester
PT1937276E (pt) 2005-10-12 2013-02-21 Besins Healthcare Luxembourg Gel de testosterona melhorado e método para a sua utilização
CN101516255A (zh) * 2006-09-13 2009-08-26 皇家飞利浦电子股份有限公司 用于自动调整褪黑素的剂量和/或递送褪黑素的装置
LT2653873T (lt) 2007-02-08 2022-10-10 Biogen Ma Inc. Kompozicijos ir naudojimas, skirti išsėtinei sklerozei gydyti
DE102008036825A1 (de) * 2008-08-05 2010-02-11 Aicuris Gmbh & Co. Kg Schwangerschaftsvermeidung durch Gestagene
FR2937862B1 (fr) * 2008-11-03 2010-11-19 Mohammed Ridha Chakroun Kit contraceptif
WO2015144965A1 (es) * 2014-03-27 2015-10-01 Servicio Andaluz De Salud Preparación duradera de inyectable de melatonina estable a largo plazo
RU2617518C2 (ru) * 2015-07-01 2017-04-25 Общество с ограниченной ответственностью "Научно-внедренческий центр Агроветзащита" Способ регулирования полового поведения и контрацепции самок млекопитающих
RU2616252C2 (ru) * 2015-08-04 2017-04-13 Общество с ограниченной ответственностью "Научно-внедренческий центр Агроветзащита" Способ регулирования полового поведения самцов млекопитающих

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4087444A (en) * 1976-09-08 1978-05-02 Eli Lilly And Company Amides as ovulation inhibitors
DE2967049D1 (en) * 1978-04-11 1984-07-19 Efamol Ltd Pharmaceutical and dietary composition comprising gamma-linolenic acids
US4425339A (en) * 1981-04-09 1984-01-10 Syntex (U.S.A.) Inc. Treatment of menopausal symptoms
US4390531A (en) * 1981-08-10 1983-06-28 Syntex Pharmaceuticals International Ltd. Method of contraception using peak progestogen dosage
US4628051A (en) * 1983-09-26 1986-12-09 Ortho Pharmaceutical Corporation Triphasic oral contraceptive
US4614807A (en) * 1984-10-04 1986-09-30 Eli Lilly And Company 6,7-dihalomelatonins
WO1986005093A2 (en) * 1985-03-04 1986-09-12 Cellena (Cell Engineering) A.G. Melatonin compositions and uses thereof
US4746674A (en) * 1985-08-27 1988-05-24 Cellena (Cell Engineering) Ag Melatonin compositions and uses thereof
US4997845A (en) * 1987-02-02 1991-03-05 Eli Lilly And Company β-alkylmelatonins as ovulation inhibitors

Also Published As

Publication number Publication date
IL85814A0 (en) 1990-02-09
AU1683088A (en) 1988-11-02
PH26709A (en) 1992-09-15
US4855305A (en) 1989-08-08
CA1322527C (en) 1993-09-28
AU5513494A (en) 1994-04-14
DE3855606T2 (de) 1997-02-13
EG18583A (en) 1993-06-30
ZA882079B (en) 1988-09-15
DE3855606D1 (de) 1996-11-14
HU208487B (en) 1993-11-29
JPH1171276A (ja) 1999-03-16
KR890700349A (ko) 1989-04-24
ES2009251A6 (es) 1989-09-16
EP0354921B1 (en) 1996-10-09
FI894423A0 (fi) 1989-09-19
EP0354921A1 (en) 1990-02-21
PT87053A (pt) 1989-03-30
OA09134A (en) 1991-10-31
AU628784B2 (en) 1992-09-24
IL85814A (en) 1992-05-25
WO1988007370A1 (en) 1988-10-06
AU676523B2 (en) 1997-03-13
JP2965160B2 (ja) 1999-10-18
PT87053B (pt) 1993-09-30
DD269557A5 (de) 1989-07-05
CN1041383C (zh) 1998-12-30
RU2114621C1 (ru) 1998-07-10
HUT52954A (en) 1990-09-28
GR1002146B (en) 1996-02-19
AU8693891A (en) 1991-12-19
GR880100177A (el) 1989-01-31
JPH02502724A (ja) 1990-08-30
NZ223989A (en) 1991-08-27
BR8807426A (pt) 1990-04-10
FI894423A (fi) 1989-09-19
CN88101379A (zh) 1988-10-05
EP0354921A4 (en) 1991-08-07
BG51075A1 (en) 1993-02-15
ATE143807T1 (de) 1996-10-15

Similar Documents

Publication Publication Date Title
IN166946B (ja)
PL323729A1 (en) Skin sticking plaster and method of administering sole 17-deacetyl norgestimate or together with estrogen
IL92069A0 (en) Contraception system and method
EP0159671A3 (en) Anatomical pad
ZA913282B (en) Dosage form
ZA8410015B (en) Multistage combination preparation and its use for oral contraception
AR028809A1 (es) Un metodo anticonceptivo y una unidad anticonceptiva oral trifasica
MY121623A (en) Methods of preventing breast cancer.
CA2056364A1 (en) Compositions and methods of effecting contraception
GR900100369A (en) Contraception compositions and methods
BE894860A (fr) Therapeutique adjuvante par agent progestatif
IT1243978B (it) Farmaco per uso umano, ad azione contraccettiva ed oncostatica preventiva, nei tumori del seno, dell'utero e nel melanoma.
Schlensker Treatment of menopausal complaints. Compared clinical study of Estraderm TTS and Gynodian Depot.
MX9604426A (es) Reduccion de irritacion de la piel durante el surtido por electrotransporte.
Qi et al. Hemodynamic assessment of intravenous Isosorbidi Dinitras in coronary heart disease
Koreneva et al. Endocrinological aspects of rehabilitating women following induced abortion
UA13709A1 (uk) Спосіб лікуваhhя аhемії вагітhих